XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,419,416 | -11.3% | 100,100 | 0.0% | 0.01% | -9.1% |
| Q2 2023 | $3,853,850 | +47.5% | 100,100 | +37.1% | 0.01% | +37.5% |
| Q1 2023 | $2,612,670 | +39.8% | 73,000 | +54.0% | 0.01% | +33.3% |
| Q4 2022 | $1,868,982 | +88.2% | 47,400 | +72.4% | 0.01% | +100.0% |
| Q3 2022 | $993,000 | +48.4% | 27,500 | +25.0% | 0.00% | +50.0% |
| Q2 2022 | $669,000 | -47.9% | 22,000 | -47.6% | 0.00% | -33.3% |
| Q1 2022 | $1,284,000 | -2.1% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,312,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |